Chicago, IL, United States of America

Jasmina Marjanovic

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

As a client interested in innovations and inventors, here is the article about inventor Jasmina Marjanovic:

Title: Unveiling the Inventive Genius of Jasmina Marjanovic

Introduction:

Jasmina Marjanovic, a brilliant inventor based in Chicago, IL, has made significant contributions to the field of pharmaceuticals with his groundbreaking patents. With a portfolio boasting three patents, Jasmina Marjanovic is a name to reckon with in the innovation landscape.

Latest Patents:

Marjanovic's latest patents revolve around Bromodomain inhibitors, a class of compounds essential in treating a myriad of diseases such as inflammatory conditions, cancer, and AIDS. These patents encompass compounds of formula (I) and their pharmaceutical compositions, showcasing Marjanovic's expertise in developing novel agents for disease treatment.

Career Highlights:

Currently affiliated with AbbVie Inc., a prominent pharmaceutical company known for its cutting-edge research, Marjanovic has thrived in an environment that nurtures innovation. His relentless pursuit of scientific excellence has propelled him to the forefront of the industry.

Collaborations:

In his journey of discovery, Marjanovic has had the privilege of collaborating with esteemed colleagues such as Steven D Fidanze and Keith F McDaniel. Together, they have synergized their expertise to drive forward groundbreaking research initiatives.

Conclusion:

Jasmina Marjanovic's inventive prowess is evident in his patent portfolio, solidifying his position as a visionary inventor in the pharmaceutical realm. His relentless dedication to advancing healthcare solutions underscores the importance of innovation in tackling complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…